| Discovery of cryptic allosteric sites using reversed allosteric communication by a combined computational and experimental strategy D Ni, J Wei, X He, AU Rehman, X Li, Y Qiu, J Pu, S Lu, J Zhang Chemical science 12 (1), 464-476, 2021 | 92 | 2021 |
| Emergence of allosteric drug-resistance mutations: new challenges for allosteric drug discovery S Lu, Y Qiu, D Ni, X He, J Pu, J Zhang Drug discovery today 25 (1), 177-184, 2020 | 72 | 2020 |
| Combining allosteric and orthosteric drugs to overcome drug resistance D Ni, Y Li, Y Qiu, J Pu, S Lu, J Zhang Trends in pharmacological sciences 41 (5), 336-348, 2020 | 70 | 2020 |
| Mechanistic insights into the effect of phosphorylation on Ras conformational dynamics and its interactions with cell signaling proteins Y Wang, D Ji, C Lei, Y Chen, Y Qiu, X Li, M Li, D Ni, J Pu, J Zhang, Q Fu, ... Computational and Structural Biotechnology Journal 19, 1184-1199, 2021 | 53 | 2021 |
| Untangling dual-targeting therapeutic mechanism of epidermal growth factor receptor (EGFR) based on reversed allosteric communication Y Qiu, X Yin, X Li, Y Wang, Q Fu, R Huang, S Lu Pharmaceutics 13 (5), 747, 2021 | 44 | 2021 |
| Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells Q Zhang, Y Chen, D Ni, Z Huang, J Wei, L Feng, JC Su, Y Wei, S Ning, ... Acta Pharmaceutica Sinica B 12 (2), 876-889, 2022 | 37 | 2022 |
| Computational methods-guided design of modulators targeting protein-protein interactions (PPIs) Y Qiu, X Li, X He, J Pu, J Zhang, S Lu European Journal of Medicinal Chemistry 207, 112764, 2020 | 35 | 2020 |
| Targeting RAS phosphorylation in cancer therapy: Mechanisms and modulators Y Qiu, Y Wang, Z Chai, D Ni, X Li, J Pu, J Chen, J Zhang, S Lu, C Lv, M Ji Acta Pharmaceutica Sinica B 11 (11), 3433-3446, 2021 | 23 | 2021 |
| Conformational selection mechanism provides structural insights into the optimization of APC-Asef inhibitors X He, N Huang, Y Qiu, J Zhang, Y Liu, XL Yin, S Lu Molecules 26 (4), 962, 2021 | 11 | 2021 |
| Cardiovascular toxicity of tyrosine kinase inhibitors during cancer treatment: Potential involvement of TRPM7 Q Liu, S Li, Y Qiu, J Zhang, FJ Rios, Z Zou, RM Touyz Frontiers in Cardiovascular Medicine 10, 1002438, 2023 | 2 | 2023 |
| Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypes YH Huang, YR Qiu, QL Zhang, MC Cai, H Yu, JM Zhang, L Jiang, MM Ji, ... Cell Reports Medicine, 2024 | | 2024 |
| Precise diagnosis and treatment for peripheral T-cell lymphomas: From pathogenic mechanisms to innovative approaches Y Qiu, W Zhao The Innovation Medicine, 100048-1-100048-23, 2024 | | 2024 |
